KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Exact Sciences (EXAS) Shares Outstanding (2016 - 2025)

Exact Sciences has reported Shares Outstanding over the past 16 years, most recently at $190.8 million for Q4 2025.

  • Quarterly Shares Outstanding rose 2.79% to $190.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $190.8 million through Dec 2025, up 2.79% year-over-year, with the annual reading at $190.8 million for FY2025, 2.79% up from the prior year.
  • Shares Outstanding was $190.8 million for Q4 2025 at Exact Sciences, up from $189.5 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $190.8 million in Q4 2025 and troughed at $171.3 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $180.7 million (2023), against an average of $180.8 million.
  • Year-over-year, Shares Outstanding grew 14.62% in 2021 and then rose 1.93% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $173.7 million in 2021, then rose by 2.45% to $177.9 million in 2022, then increased by 1.93% to $181.4 million in 2023, then grew by 2.34% to $185.6 million in 2024, then grew by 2.79% to $190.8 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Shares Outstanding are $190.8 million (Q4 2025), $189.5 million (Q3 2025), and $189.2 million (Q2 2025).